Filter by: patients
Home > Community Treatment Reports and Side Effects > Cabergoline Treatment Report
What is Cabergoline?

Cabergoline is an ergot-derived dopamine agonist used in the treatment of Parkinson's disease. Due to elevated levels of heart problems, ergot-derived agonists are being phased out of clinical use.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Prolactinoma 9 0
Parkinson's Disease 8 6 Efficacy_major Efficacy_cant_tell
Other 3 0
Hypogonadism 2 0
Acromegaly Syndrome 1 0
Depressed mood 1 1 Efficacy_none

See all 19 patients currently taking Cabergoline

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 2
Moderate
 1
Mild
 2
None
 3

Commonly reported side effects, conditions, and hospitalizations associated with Cabergoline

Generalized muscle aches 1
Low blood pressure 1
Dizziness 1
Dry skin 1
Tiredness 1
Blurry vision in left eye 1
See all 13 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

Frequently reported dosages based on patients currently taking Cabergoline. See all 12 dosages ►

  0.5 mg weekly 0.1 mg daily 0.75 mg weekly 1 mg weekly 3 mg weekly 0.5 mg daily 5 mg weekly 0.75 mg daily 2 mg daily 8 mg daily
  6 Number of Patients: 6 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Cabergoline (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 6   Doctor's advice: 67%
Side effects too severe 2   Side effects too severe: 22%
Course of treatment ended 1   Course of treatment ended: 11%
Change in health plan coverage 1   Change in health plan coverage: 11%

See all 9 patients who’ve stopped taking Cabergoline

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Cabergoline

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Stopped Taking Cabergoline

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Cabergoline

Always
 6 75%
Usually
 0 0%
Sometimes
 1 13%
Never
 1 13%

Burden

Difficulty being on treatment

Burden of Cabergoline

Very
 0 0%
Somewhat
 1 13%
A little
 0 0%
Not at all
 7 88%

Cost

Paid out of pocket

Cost of Cabergoline

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 3 50%
< $25
 3 50%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 27, 2012.